{
    "abstract": "The corona virus disease -2019 (COVID-19) pandemic has caused a massive global public health havoc. Recent published clinical trials show conflicting data for use of chloroquine/hydroxychloroquine for COVID-19. This study meticulously evaluated the various dosages of chloroquine and hydroxychloroquine utilized in clinical trials registered in Chinese and US clinical trial registries for the treatment of pneumonia caused by SARS-CoV-2. Moreover, the results of published clinical trials and in vitro studies using chloroquine and hydroxychloroquine relevant to the disease are discussed.",
    "author": "Divya RSJB Rana; Santosh Dulal",
    "date": 2020,
    "doi": "10.1101/2020.03.22.20040964",
    "identifiers": {
        "url": "http://medrxiv.org/cgi/content/short/2020.03.22.20040964"
    },
    "title": "Therapeutic Application of Chloroquine and Hydroxychloroquine in Clinical Trials for COVID-19: A systematic review",
    "funding": [
        {
            "award-group": [],
            "funding-statement": "Not applicable"
        }
    ]
}